The Cost of Manual Verification
How Eligibility Verification Actually Works
Clearinghouse and RCM Platforms
Standalone Verification Solutions
AI-Powered Platforms
Feature Comparison and Selection Guide
Platform | Real-Time | Batch | Specialty BV | PA Integration | Coverage Discovery | Pricing Transparency |
|---|---|---|---|---|---|---|
Waystar | Yes | Yes | Partial | Yes | Yes | Contact |
Availity | Yes | Yes | Partial | Yes | Limited | Free tier + paid |
TriZetto | Yes | Yes | Partial | Yes | Yes | Contact |
Experian Health | Yes | Yes | Partial | Yes | Yes | Contact |
pVerify | Yes | Yes | Limited | No | Yes | Published |
Inovalon | Yes | Yes | Yes | Yes | Yes | Contact |
CERTIFY Health | Yes | Yes | Limited | No | Limited | Contact |
maxRTE | Yes | Yes | Limited | No | Yes | Published |
Office Ally | Yes | Yes | Limited | No | Limited | Free |
Tebra | Yes | Yes | Limited | Limited | Limited | Published |
CloudRCM | Yes | Yes | Limited | Yes | Yes | Contact |
Neon Health | Yes | N/A | Full | Full | N/A | Contact |
Infinx | Yes | Yes | Yes | Yes | Yes | Contact |
Thoughtful AI | Yes | Yes | Limited | Yes | Yes | Contact |
How to Actually Choose
Your selection depends on organization type, verification volume, and workflow requirements. A few things worth thinking through:
Real-time vs. batch: Do you need results at point of service, or can you process overnight for scheduled patients? Most practices need real-time, but high-volume operations benefit from batch.
Specialty medication support: If you prescribe or dispense specialty medications, basic EDI won't cut it. You need therapy-specific verification, step therapy identification, PA requirement detection, specialty pharmacy network status, and accumulator information. Standard platforms mark this as "Limited" for a reason.
PA integration: Verification often triggers PA workflows. Platforms with integrated PA management reduce handoffs.
Pricing and ROI: Calculate verification volume, compare pricing models (per-transaction vs. subscription vs. percentage of collections), and estimate ROI against current manual costs.
By Organization Type
Small practice (1-5 providers): Prioritize low cost and ease of use. Office Ally (free), maxRTE (transparent pricing), or Tebra (if you want the full platform). Avoid enterprise platforms - too much complexity for what you need.
Mid-size practice (6-50 providers): Workflow integration and real-time verification matter more. Look at pVerify, Availity Essentials Pro, or CERTIFY Health. Consider whether standalone verification or integrated RCM makes more sense for your operation.
Health system (50+ providers): Enterprise scalability, EHR integration, and analytics are priorities. Waystar, Experian Health, or TriZetto. Factor in total cost of ownership including implementation.
Specialty pharmacy: Standard eligibility platforms won't meet your needs. Consider Neon Health, Infinx, or Inovalon - platforms built for specialty complexity.
Where the Market Is Heading
The eligibility verification market is splitting into two tiers.
Commodity verification: Basic real-time eligibility will remain widely available at low or no cost through clearinghouses and free platforms. For standard office visits and procedures, this is often sufficient.
Value-added verification: Specialty-aware, AI-powered verification that goes beyond EDI will command premium pricing but deliver measurable ROI for complex cases.
What's driving the shift? Standard EDI transactions return structured data based on service type codes - they work well for many use cases. But for specialty medications, the gaps are significant: therapy-specific coverage, step therapy requirements, accumulator status, PA requirements for newly launched drugs. AI-powered platforms address these through intelligent portal automation, document interpretation, voice automation (calling payer lines directly), and workflow orchestration.
For organizations handling primarily standard visits and procedures, commodity solutions are fine. For those dealing with specialty medications, complex procedures, or high denial rates, the AI-powered alternatives are worth serious evaluation.
Sources:
• CAQH. "2024 CAQH Index Report." CAQH, 2024.
• MGMA. Medical Group Management Association data on claim reprocessing costs.
• Neon Health. "Understanding Benefit Verification: A Technical Breakdown." Neon Health Blog.
• IQVIA Institute. "The Use of Medicines in the U.S." IQVIA, 2024.
• JMCP. "Specialty Drug Spending in Medicare Part D." Journal of Managed Care & Specialty Pharmacy. PMID: 39612254.
• Vendor websites for platform-specific information. Accessed January 2026.



